Kim SM - Search Results

1

NgR1 is an NK cell inhibitory receptor that destabilizes the immunological synapse.

Oh SC, Kim SE, Jang IH, Kim SM, Lee SY, Lee S, Chu IS, Yoon SR, Jung H, Choi I, Doh J, Kim TD. Oh SC, et al. Among authors: kim td, kim se, kim sm. Nat Immunol. 2023 Mar;24(3):463-473. doi: 10.1038/s41590-022-01394-w. Epub 2023 Jan 9. Nat Immunol. 2023. PMID: 36624164

2

MicroRNA-150 controls differentiation of intraepithelial lymphocytes through TGF-β receptor II regulation.

Seo SH, Jang MS, Kim DJ, Kim SM, Oh SC, Jung CR, Park Y, Ha SJ, Jung H, Park YJ, Yoon SR, Choi I, Kim TD. Seo SH, et al. Among authors: kim td, kim dj, kim sm. J Allergy Clin Immunol. 2018 Apr;141(4):1382-1394.e14. doi: 10.1016/j.jaci.2017.07.019. Epub 2017 Aug 7. J Allergy Clin Immunol. 2018. PMID: 28797734

3

miR-150-Mediated Foxo1 Regulation Programs CD8⁺ T Cell Differentiation.

Ban YH, Oh SC, Seo SH, Kim SM, Choi IP, Greenberg PD, Chang J, Kim TD, Ha SJ. Ban YH, et al. Among authors: kim td, kim sm. Cell Rep. 2017 Sep 12;20(11):2598-2611. doi: 10.1016/j.celrep.2017.08.065. Cell Rep. 2017. PMID: 28903041 Free article.

4

A three-dimensional hyaluronic acid-based niche enhances the therapeutic efficacy of human natural killer cell-based cancer immunotherapy.

Ahn YH, Ren L, Kim SM, Seo SH, Jung CR, Kim DS, Noh JY, Lee SY, Lee H, Cho MY, Jung H, Yoon SR, Kim JE, Lee SN, Kim S, Shin IW, Shin HS, Hong KS, Lim YT, Choi I, Kim TD. Ahn YH, et al. Among authors: kim ds, kim td, kim s, kim sm, kim je. Biomaterials. 2020 Jul;247:119960. doi: 10.1016/j.biomaterials.2020.119960. Epub 2020 Mar 7. Biomaterials. 2020. PMID: 32278822

5

RNA demethylation by FTO stabilizes the FOXJ1 mRNA for proper motile ciliogenesis.

Kim H, Lee YS, Kim SM, Jang S, Choi H, Lee JW, Kim TD, Kim VN. Kim H, et al. Among authors: kim td, kim vn, kim sm. Dev Cell. 2021 Apr 19;56(8):1118-1130.e6. doi: 10.1016/j.devcel.2021.03.006. Epub 2021 Mar 23. Dev Cell. 2021. PMID: 33761320 Free article.

6

The Role of IL-7 and IL-7R in Cancer Pathophysiology and Immunotherapy.

Wang C, Kong L, Kim S, Lee S, Oh S, Jo S, Jang I, Kim TD. Wang C, et al. Int J Mol Sci. 2022 Sep 8;23(18):10412. doi: 10.3390/ijms231810412. Int J Mol Sci. 2022. PMID: 36142322 Free PMC article. Review.

7

A modifiable universal cotinine-chimeric antigen system of NK cells with multiple targets.

Kang HY, Lee SY, Kim HM, Lee SU, Lee H, Cho MY, Oh SC, Kim SM, Park HS, Han EH, Kim SE, Kim H, Yoon SR, Doh J, Chung J, Hong KS, Choi I, Kim TD. Kang HY, et al. Among authors: kim td, kim h, kim se, kim hm, kim sm. Front Immunol. 2023 Jan 13;13:1089369. doi: 10.3389/fimmu.2022.1089369. eCollection 2022. Front Immunol. 2023. PMID: 36713381 Free PMC article.

8

FTO negatively regulates the cytotoxic activity of natural killer cells.

Kim SM, Oh SC, Lee SY, Kong LZ, Lee JH, Kim TD. Kim SM, et al. Among authors: kim td. EMBO Rep. 2023 Apr 5;24(4):e55681. doi: 10.15252/embr.202255681. Epub 2023 Feb 6. EMBO Rep. 2023. PMID: 36744362 Free PMC article.

9

NK cells encapsulated in micro/macropore-forming hydrogels via 3D bioprinting for tumor immunotherapy.

Kim D, Jo S, Lee D, Kim SM, Seok JM, Yeo SJ, Lee JH, Lee JJ, Lee K, Kim TD, Park SA. Kim D, et al. Among authors: kim td, kim sm. Biomater Res. 2023 Jun 22;27(1):60. doi: 10.1186/s40824-023-00403-9. Biomater Res. 2023. PMID: 37349810 Free PMC article.

10

Understanding nucleic acid sensing and its therapeutic applications.

Kong LZ, Kim SM, Wang C, Lee SY, Oh SC, Lee S, Jo S, Kim TD. Kong LZ, et al. Among authors: kim td, kim sm. Exp Mol Med. 2023 Nov;55(11):2320-2331. doi: 10.1038/s12276-023-01118-6. Epub 2023 Nov 9. Exp Mol Med. 2023. PMID: 37945923 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,434 results

Search Page